Retrospective analysis based on a clinical grading system for patients with hepatic hemangioma: A single center experience

Table 2 Clinical characteristics and laboratory data of the patients with hepatic hemangioma

Characteristics	Score < 4		Score ≥ 4		F/χ2	P value
	Observation (n = 352)	Surgery (n = 460)	Observation (n = 77)	Surgery (n = 282)
Age (year)	46 (39, 52)	44 (39, 51)	42 (36, 54)	45 (39, 50)	0.55	0.65
HBV positive, n (%)	18 (5.11)	34 (7.39)	6 (7.79)	17 (6.03)	-	0.54
HCV positive, n (%)	3 (0.85)	1 (0.22)	0	1 (0.35)	-	0.61
Total bilirubin (μmol/L)	11.80 (9.25, 15.71)	11.76 (9.17, 15.19)	12.70 (9.42, 16.27)	11.50 (9.41, 11.51)	0.92	0.43
Albumin (g/L)	40.09 (37.63, 43)	40.95 (38, 43.9)	40 (37.65, 46.88)	40.51 (37.7, 43.51)	1.04	0.37
AST (U/L)	18.70 (15.6, 23.95)	18.20 (15.43, 22)	18 (15.3, 22.55)	18.5 (15.78, 21.9)	0.89	0.45
ALT (U/L)	17.7 (13, 25.2)	17.55 (12.85, 24.42)	16.2 (11.65, 23.2)	17.6 (12.7, 24.7)	0.46	0.71
Child-Pugh Grade A, n (%)	349 (99.15)	452 (98.26)	75 (97.40)	278 (98.58)	-	0.51
Coagulopathy (n)	0	0	0	0	-	-

HBV: Hepatitis B virus; HCV: Hepatitis C virus; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase.